Le Lézard
Classified in: Health, Science and technology, Business
Subject: JVN

Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy


BUDAPEST, Hungary, June 1, 2023 /CNW/ -- Mediso Medical Imaging Systems recently installed a state-of-the-art 7T MRI at the University of Milano-Bicocca. The nanoScan® MRI 7T installed is equipped with a state-of-the-art cryogen-free superconducting magnet. Uniquely on the preclinical market, the pulse tube cryocooler is mounted at the back of the scanner to minimize vibrations thus delivering ghost-free images. The ultra-high magnetic field of 7T along with the robust low-noise gradients enables high-end in vivo applications such as DTI or MR Spectroscopy with excellent SNR. Due to the patented SmartMagnettm technology the recovery time of the magnet is very fast even after day-long maintenance or service intervals.

Prof. Rosa Maria Moresco Professor at the department of Medicine and Surgery at University of Milano-Bicocca commented.

"The preclinical research groups of the Department of Medicine and Surgery of University of Milano-Bicocca are very pleased to include in the imaging facilities the nanoScan® 7T preclinical MRI scanner. With the system we will implement novel in vivo diagnostic procedures and better characterize the preclinical models of diseases under development based on established imaging features derived from clinical knowledge."

Gerg? Bagaméry, Director of Preclinical Product Development at Mediso commented: "Combining the ultra-high field of 7T with a magnet that has very low installation and maintenance requirements will allow researchers not to compromise their image quality and quantitation accuracy due to limitations of lab-space."

This new installation at the University of Milano-Bicocca represents a significant milestone for Mediso, as it is the first nanoScan® MRI installation in Italy considered as a stepping stone for the company to achieve significant growth in the region.

About Mediso:

Mediso works in the field of medical imaging for 30+ years with a profile of development, manufacturing, selling and servicing standalone and multi-modality imaging devices. The company offers complete solutions from hardware design to evaluation and quantification software for clinical patient care and preclinical research.

Mediso has a leader position in the preclinical imaging market with over 300 commissioned systems around the world. Beyond the market leading nanoScan® PET/CT and SPECT/CT, Mediso also offers standalone MRI and integrated PET/MRI systems based on a cryogen-free magnet with 3T or 7T field strength and a PET insert for simultaneous PET/MRI imaging.

Products are sold directly or through a distribution network in 100+ countries worldwide.

Photo - https://mma.prnewswire.com/media/2076999/Mediso.jpg
Logo - https://mma.prnewswire.com/media/2077004/Mediso_Logo.jpg

Mediso Logo

SOURCE Mediso


These press releases may also interest you

at 21:30
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

at 21:20
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....

at 20:00
The 5p- Society of North America, along with families and support organizations from over 95 countries, are bringing awareness of 5p Deletion Syndrome also known as 5p Minus (5p-)...

at 19:31
Alleva, a leading provider of electronic medical record (EMR) solutions, attended the first-ever East Coast TCIV conference last week in Palm Beach, Florida. The company's CEO, Steve McCall, Director of Sales, John David, and Manager of Strategic...

at 18:54
The Canadian Food Inspection Agency (CFIA) has confirmed the presence of emerald ash borer (EAB - Agrilus planipennis) in the City of Vancouver, British Columbia. These detections, which are outside of currently regulated areas for emerald ash borer...

at 18:35
Teva Pharmaceutical Industries Ltd. today announced that Richard Francis, Teva's President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024. The presentation will begin at 8:40 A.M. Pacific Time (11:40...



News published on and distributed by: